Transient receptor potential channelopathies

Molecular and Genomic Physiology


In the past years, several hereditary diseases caused by defects in transient receptor potential channels (TRP) genes have been described. This review summarizes our current knowledge about TRP channelopathies and their possible pathomechanisms. Based on available genetic indications, we will also describe several putative pathological conditions in which (mal)function of TRP channels could be anticipated.


TRP channels Channelopathies Drug targets Hereditary diseases SNP Cation channel Calcium signalling Calcium Magnesium 


  1. 1.
    Abramowitz J, Birnbaumer L (2007) Know thy neighbors: a survey of diseases and complex syndromes that map to chromosomal regions encoding TRP channels. In: Flockerzi V, Nilius B (eds) TRP channels. Springer, New York, pp 377–406Google Scholar
  2. 2.
    Abramowitz J, Birnbaumer L (2009) Physiology and pathophysiology of canonical transient receptor potential channels. FASEB J 23:297–328PubMedCrossRefGoogle Scholar
  3. 3.
    Alexander RT, Hoenderop JG, Bindels RJ (2008) Molecular determinants of magnesium homeostasis: insights from human disease. J Am Soc Nephrol 19:1451–1458PubMedCrossRefGoogle Scholar
  4. 4.
    Andrade YN, Fernandes J, Vazques E, F-F JM, Arniges M, Sanchez TM, Villalon M, Valverde MA (2005) TRPV4 channel is involved in the coupling of the fluid viscosity changes to epithelial ciliary activity. J Cell Biol 168:869–874PubMedCrossRefGoogle Scholar
  5. 5.
    Audo I, Kohl S, Leroy BP, Munier FL, Guillonneau X, Mohand-Said S, Bujakowska K, Nandrot EF, Lorenz B, Preising M, Kellner U, Renner AB, Bernd A, Antonio A, Moskova-Doumanova V, Lancelot ME, Poloschek CM, Drumare I, Defoort-Dhellemmes S, Wissinger B, Leveillard T, Hamel CP, Schorderet DF, De Baere E, Berger W, Jacobson SG, Zrenner E, Sahel JA, Bhattacharya SS, Zeitz C (2009) TRPM1 is mutated in patients with autosomal-recessive complete congenital stationary night blindness. Am J Hum Genet 85:720–729PubMedCrossRefGoogle Scholar
  6. 6.
    Auer-Grumbach M, Olschewski A, Papic L, Kremer H, McEntagart ME, Uhrig S, Fischer C, Fröhlich E, Balint Z, Tang B, Strohmaier H, Lochmüller H, Schlotter-Weigel B, Senderek J, Krebs A, Dick KJ, Petty R, Longman C, Anderson NE, Padberg GW, Schelhaas HJ, van Ravenswaaij-Arts C, Pieber TR, Crosby AH, Guelly C (2010) Mutations in the N-terminal ankyrin domain of TRPV4 cause congenital and scapuloperoneal spinal muscular atrophy, and hereditary motor and sensory neuropathy 2C. Nat Genet 42:160–164Google Scholar
  7. 7.
    Bach G (2001) Mucolipidosis type IV. Mol Genet Metab 73:197–203PubMedCrossRefGoogle Scholar
  8. 8.
    Bach G (2005) Mucolipin 1: endocytosis and cation channel—a review. Pflugers Arch Eur J Physiol 451:313–317CrossRefGoogle Scholar
  9. 9.
    Bargal R, Avidan N, Olender T, Ben Asher E, Zeigler M, Raas-Rothschild A, Frumkin A, Ben-Yoseph O, Friedlender Y, Lancet D, Bach G (2001) Mucolipidosis type IV: novel MCOLN1 mutations in Jewish and non-Jewish patients and the frequency of the disease in the Ashkenazi Jewish population. Hum Mutat 17:397–402PubMedCrossRefGoogle Scholar
  10. 10.
    Bassi MT, Manzoni M, Monti E, Pizzo MT, Ballabio A, Borsani G (2000) Cloning of the gene encoding a novel integral membrane protein, mucolipidin—and identification of the two major founder mutations causing mucolipidosis type IV. Am J Hum Genet 67:1110–1120PubMedGoogle Scholar
  11. 11.
    Becker EBE, Oliver PL, Glitsch MD, Banks GT, Achillic F, Hardy A, Noland PM, Fisher EMC, Kay E, Davies KA (2009) A point mutation in TRPC3 causes abnormal Purkinje cell development and cerebellar ataxia in moonwalker mice. Proc Natl Acad Sci USA 106:6706–6711PubMedCrossRefGoogle Scholar
  12. 12.
    Bellone RR, Brooks SA, Sandmeyer L, Murphy BA, Forsyth G, Archer S, Bailey E, Grahn B (2008) Differential gene expression of TRPM1, the potential cause of congenital stationary night blindness (CSNB) and coat spotting patterns (LP) in the Appaloosa horse (Equus caballus). Genetics 179:1861–1870PubMedCrossRefGoogle Scholar
  13. 13.
    Benarroch EE (2008) TRP channels: functions and involvement in neurologic disease. Neurology 70:648–652PubMedCrossRefGoogle Scholar
  14. 14.
    Benezra R (2005) Polycystins: inhibiting the inhibitors. Nat Cell Biol 7:1064–1065CrossRefGoogle Scholar
  15. 15.
    Boletta A, Germino GG (2003) Role of polycystins in renal tubulogenesis. Trends Cell Biol 13:484–492PubMedCrossRefGoogle Scholar
  16. 16.
    Brechard S, Melchior C, Plancon S, Schenten V, Tschirhart EJ (2008) Store-operated Ca(2+) channels formed by TRPC1, TRPC6 and Orai1 and non-store-operated channels formed by TRPC3 are involved in the regulation of NADPH oxidase in HL-60 granulocytes. Cell Calcium 44:492–506PubMedCrossRefGoogle Scholar
  17. 17.
    Burtey S, Riera M, Ribe E, Pennekamp P, Passage E, Rance R, Dworniczak B, Fontes M (2007) Overexpression of PKD2 in the mouse is associated with renal tubulopathy. Nephrol Dial Transplant 23:1157–1165PubMedCrossRefGoogle Scholar
  18. 18.
    Calcraft PJ, Ruas M, Pan Z, Cheng X, Arredouani A, Hao X, Tang J, Rietdorf K, Teboul L, Chuang KT, Lin P, Xiao R, Wang C, Zhu Y, Lin Y, Wyatt CN, Parrington J, Ma J, Evans AM, Galione A, Zhu MX (2009) NAADP mobilizes calcium from acidic organelles through two-pore channels. Nature 459:596–600PubMedCrossRefGoogle Scholar
  19. 19.
    Chen CS, Bach G, Pagano RE (1998) Abnormal transport along the lysosomal pathway in mucolipidosis, type IV disease. Proc Natl Acad Sci U S A 95:6373–6378PubMedCrossRefGoogle Scholar
  20. 20.
    Chubanov V, Gudermann T, Schlingmann KP (2005) Essential role for TRPM6 in epithelial magnesium transport and body magnesium homeostasis. Pflugers Arch Eur J Physiol 451:228–234CrossRefGoogle Scholar
  21. 21.
    Chubanov V, Schlingmann KP, Waring J, Heinzinger J, Kaske S, Waldegger S, Schnitzler MM, Gudermann T (2007) Hypomagnesemia with secondary hypocalcemia due to a missense mutation in the putative pore-forming region of TRPM6. J Biol Chem 282:7656–7667PubMedCrossRefGoogle Scholar
  22. 22.
    Cuajungco MP, Samie MA (2008) The varitint-waddler mouse phenotypes and the TRPML3 ion channel mutation: cause and consequence. Pflugers Arch Eur J Physiol 457:463–473CrossRefGoogle Scholar
  23. 23.
    Curcio-Morelli C, Zhang P, Venugopal B, Charles FA, Browning MF, Cantiello HF, Slaugenhaupt SA (2009) Functional multimerization of mucolipin channel proteins. J Cell Physiol 222:328–335CrossRefGoogle Scholar
  24. 24.
    Delmas P (2004) Polycystins: from mechanosensation to gene regulation. Cell 118:145–148PubMedCrossRefGoogle Scholar
  25. 25.
    Delmas P (2005) Polycystins: polymodal receptor/ion-channel cellular sensors. Pflugers Arch Eur J Physiol 451:264–276CrossRefGoogle Scholar
  26. 26.
    Delmas P, Padilla F, Osorio N, Coste B, Raoux M, Crest M (2004) Polycystins, calcium signaling, and human diseases. Biochem Biophys Res Commun 322:1374–1383PubMedCrossRefGoogle Scholar
  27. 27.
    Deng H-X, Klein CJ, Yan J, Shi S, Wu Y, Fecto F, Yau H, Yang Y, Zhai H, Siddique N, Hedley-Whyte ET, DeLong R, Martina M, Dyck PJ, Siddique T (2010) Scapuloperoneal spinal muscular atrophy and hereditary motor and sensory neuropathy type IIC are allelic disorders caused by mutations in TRPV4. Nat Genet 42:165–169Google Scholar
  28. 28.
    Di Palma F, Belyantseva I, Kim H, Vogt T, Kachar B, Noben-Trauth K (2002) Mutations in Mcoln3 associated with deafness and pigmentation defects in varitint-waddler (Va) mice. Proc Natl Acad Sci U S A 99:14994–14999PubMedCrossRefGoogle Scholar
  29. 29.
    Dietrich A, Chubanov V, Kalwa H, Rost BR, Gudermann T (2006) Cation channels of the transient receptor potential superfamily: their role in physiological and pathophysiological processes of smooth muscle cells. Pharmacol Ther 112:744–760PubMedCrossRefGoogle Scholar
  30. 30.
    Dietrich A, Kalwa H, Fuchs B, Grimminger F, Weissmann N, Gudermann T (2007) In vivo TRPC functions in the cardiopulmonary vasculature. Cell Calcium 455:465–477Google Scholar
  31. 31.
    Dong X-P, Cheng X, Mills E, Delling M, Wang F, Kurz T, Xu H (2008) The type IV mucolipidosis-associated protein TRPML1 is an endolysosomal iron release channel. Nature 455:992–996PubMedCrossRefGoogle Scholar
  32. 32.
    Dong XP, Wang X, Shen D, Chen S, Liu M, Wang Y, Mills E, Cheng X, Delling M, Xu H (2009) Activating mutations of the TRPML1 channel revealed by proline scanning mutagenesis. J Biol Chem 284:32040–32052PubMedCrossRefGoogle Scholar
  33. 33.
    Drennan D, Ryazanov AG (2004) Alpha-kinases: analysis of the family and comparison with conventional protein kinases. Prog Biophys Mol Biol 85:1–32PubMedCrossRefGoogle Scholar
  34. 34.
    Duncan LM, Deeds J, Cronin FE, Donovan M, Sober AJ, Kauffman M, McCarthy JJ (2001) Melastatin expression and prognosis in cutaneous malignant melanoma. J Clin Oncol 19:568–576PubMedGoogle Scholar
  35. 35.
    Duncan LM, Deeds J, Hunter J, Shao J, Holmgren LM, Woolf EA, Tepper RI, Shyjan AW (1998) Down-regulation of the novel gene melastatin correlates with potential for melanoma metastasis. Cancer Res 58:1515–1520PubMedGoogle Scholar
  36. 36.
    Eder P, Groschner K (2008) Topical aspects of biophysics and pathophysiology. Channels 2:94–99CrossRefGoogle Scholar
  37. 37.
    Everaerts W, Nilius B, Owsianik G (2009) The vallinoid transient receptor potential channel Trpv4: from structure to disease. Prog Biophys Mol Biol (in press)Google Scholar
  38. 38.
    Everett KV, Chioza BA, Georgoula C, Reece A, Capon F, Parker KA, Cord-Udy C, McKeigue P, Mitton S, Pierro A, Puri P, Mitchison HM, Chung EM, Gardiner RM (2008) Genome-wide high-density SNP-based linkage analysis of infantile hypertrophic pyloric stenosis identifies loci on chromosomes 11q14-q22 and Xq23. Am J Hum Genet 16:1151–1154Google Scholar
  39. 39.
    Firth AL, Remillard CV, Yuan JX (2007) TRP channels in hypertension. Biochim Biophys Acta 1772:895–906PubMedGoogle Scholar
  40. 40.
    Fischer E, Legue E, Doyen A, Nato F, Nicolas JF, Torres V, Yaniv M, Pontoglio M (2006) Defective planar cell polarity in polycystic kidney disease. Nat Genet 38:21–23PubMedCrossRefGoogle Scholar
  41. 41.
    Fleig A, Penner R, Tabet F (2004) The TRPM ion channel subfamily: molecular, biophysical and functional features. Trends Pharmacol Sci 25:633–639PubMedCrossRefGoogle Scholar
  42. 42.
    Fournet JC, Mayaud C, de Lonlay P, Gross-Morand MS, Verkarre V, Castanet M, Devillers M, Rahier J, Brunelle F, Robert JJ, Nihoul-Fekete C, Saudubray JM, Junien C (2001) Unbalanced expression of 11p15 imprinted genes in focal forms of congenital hyperinsulinism: association with a reduction to homozygosity of a mutation in ABCC8 or KCNJ11. Am J Pathol 158:2177–2184PubMedGoogle Scholar
  43. 43.
    Fraser SP, Pardo LA (2008) Ion channels: functional expression and therapeutic potential in cancer. Colloquium on ion channels and cancer. EMBO Rep 9:512–515PubMedCrossRefGoogle Scholar
  44. 44.
    Galione A, Evans AM, Ma J, Parrington J, Arredouani A, Cheng X, Zhu MX (2009) The acid test: the discovery of two-pore channels (TPCs) as NAADP-gated endolysosomal Ca(2+) release channels. Pflugers Arch Eur J Physiol 458:869–876CrossRefGoogle Scholar
  45. 45.
    Gaudet R (2008) TRP channels entering the structural era. J Physiol 586:3565–3575PubMedCrossRefGoogle Scholar
  46. 46.
    Goel M, Sinkins WG, Schilling WP (2002) Selective association of TRPC channel subunits in rat brain synaptosomes. J Biol Chem 277:48303–48310PubMedCrossRefGoogle Scholar
  47. 47.
    Grantham JJ (1993) Polycystic kidney disease: hereditary and acquired. Adv Intern Med 38:409–420PubMedGoogle Scholar
  48. 48.
    Grimm C, Cuajungco MP, van Aken AFJ, Schnee M, Jörs M, Kros CJ, Ricci AJ, Heller S (2007) A helix-breaking mutation in TRPML3 leads to constitutive activity underlying deafness in the varitint-waddler mouse. Proc Natl Acad Sci USA 104:19583–19588PubMedCrossRefGoogle Scholar
  49. 49.
    Grimm DH, Karihaloo A, Cai Y, Somlo S, Cantley LG, Caplan MJ (2005) Polycystin-2 regulates proliferation and branching morphogenesis in kidney epithelial cells. J Biol Chem 281:137–144PubMedCrossRefGoogle Scholar
  50. 50.
    Harris PC, Torres VE (2009) Polycystic kidney disease. Annu Rev Med 60:321–337PubMedCrossRefGoogle Scholar
  51. 51.
    Heeringa SF, Moller CC, Du J, Yue L, Hinkes B, Chernin G, Vlangos CN, Hoyer PF, Reiser J, Hildebrandt F (2009) A novel TRPC6 mutation that causes childhood FSGS. PLoS ONE 4:e7771PubMedCrossRefGoogle Scholar
  52. 52.
    Hermosura M, Cui AM, Go G, Davenport B, Shetler C, Heizer J, Schmitz C, Mocz G, Garruto R, Perraud A-L (2008) Altered functional properties of a TRPM2 variant in Guamanian ALS and PD. Proc Natl Acad Sci USA 105:18029–18034PubMedCrossRefGoogle Scholar
  53. 53.
    Hermosura MC, Garruto RM (2007) TRPM7 and TRPM2-candidate susceptibility genes for Western Pacific ALS and PD? Biochim Biophys Acta 1772:822–835PubMedGoogle Scholar
  54. 54.
    Hermosura MC, Nayakanti H, Dorovkov MV, Calderon FR, Ryazanov AG, Haymer DS, Garruto RM (2005) A TRPM7 variant shows altered sensitivity to magnesium that may contribute to the pathogenesis of two Guamanian neurodegenerative disorders. Proc Natl Acad Sci USA 102:11510–11515PubMedCrossRefGoogle Scholar
  55. 55.
    Hoenderop JG, Nilius B, Bindels RJ (2005) Calcium absorption across epithelia. Physiol Rev 85:373–422PubMedCrossRefGoogle Scholar
  56. 56.
    Hofmann T, Obukhov AG, Schaefer M, Harteneck C, Gudermann T, Schultz G (1999) Direct activation of human TRPC6 and TRPC3 channels by diacylglycerol. Nature 397:259–263PubMedCrossRefGoogle Scholar
  57. 57.
    Hofmann T, Schaefer M, Schultz G, Gudermann T (2002) Subunit composition of mammalian transient receptor potential channels in living cells. Proc Natl Acad Sci USA 99:7461–7466PubMedCrossRefGoogle Scholar
  58. 58.
    Hughes DA, Tang K, Strotmann R, Schoneberg T, Prenen J, Nilius B, Stoneking M (2008) Parallel selection on TRPV6 in human populations. PLoS ONE 3:e1686PubMedCrossRefGoogle Scholar
  59. 59.
    Jordt SE, Ehrlich BE (2007) TRP channels in disease. Subcell Biochem 45:253–271PubMedCrossRefGoogle Scholar
  60. 60.
    Kim HJ, Li Q, Tjon-Kon-Sang S, So I, Kiselyov K, Muallem S (2007) Gain-of-function mutation in TRPML3 causes the mouse varitint-waddler phenotype. J Biol Chem 282:36138–36142PubMedCrossRefGoogle Scholar
  61. 61.
    Kim HJ, Li Q, Tjon-Kon-Sang S, So I, Kiselyov K, Soyombo AA, Muallem S (2008) A novel mode of TRPML3 regulation by extracytosolic pH absent in the varitint-waddler phenotype. EMBO J 27:1197–1205PubMedCrossRefGoogle Scholar
  62. 62.
    Kim HJ, Soyombo AA, Tjon-Kon-Sang S, So I, Muallem S (2009) The Ca(2+) channel TRPML3 regulates membrane trafficking and autophagy. Traffic 10:1157–1167PubMedCrossRefGoogle Scholar
  63. 63.
    Kiselyov K, Chen J, Rbaibi Y, Oberdick D, Tjon-Kon-Sang S, Shcheynikov N, Muallem S, Soyombo A (2005) TRP-ML1 is a lysosomal monovalent cation channel that undergoes proteolytic cleavage. J Biol Chem 280:43218–43223PubMedCrossRefGoogle Scholar
  64. 64.
    Kiselyov K, Soyombo A, Muallem S (2007) TRPpathias. J Physiol 578:641–653PubMedCrossRefGoogle Scholar
  65. 65.
    Konrad M, Schlingmann KP, Gudermann T (2004) Insights into the molecular nature of magnesium homeostasis. Am J Physiol Renal Physiol 286:F599–F605PubMedCrossRefGoogle Scholar
  66. 66.
    Kottgen M (2007) TRPP2 and autosomal dominant polycystic kidney disease. Biochim Biophys Acta 1772:836–850PubMedGoogle Scholar
  67. 67.
    Köttgen M, Buchholz B, Garcia-Gonzalez M-A, Kotsis F, Fu X, Doerken M, Boehlke C, Steffl D, Tauber R, Wegierski T, Nitschke R, Suzuki M, Kramer-Zucker A, Germino GG, Watnick T, Prenen J, Nilius B, Kuehn EW, Walz G (2008) TRPP2 and TRPV4 form a polymodal sensory channel complex. J Cell Biol 182:437–447PubMedCrossRefGoogle Scholar
  68. 68.
    Köttgen M, Walz G (2005) Subcellular localization and trafficking of polycystins. Pflügers Arch Europ J Physiol 451:286–293CrossRefGoogle Scholar
  69. 69.
    Koulen P, Cai Y, Geng L, Maeda Y, Nishimura S, Witzgall R, Ehrlich BE, Somlo S (2002) Polycystin-2 is an intracellular calcium release channel. Nat Cell Biol 4:191–197PubMedCrossRefGoogle Scholar
  70. 70.
    Kraft R, Harteneck C (2005) The mammalian melastatin-related transient receptor potential cation channels: an overview. Pflugers Arch Eur J Physiol 451:204–211CrossRefGoogle Scholar
  71. 71.
    Krakow D, Vriens J, Camacho N, Luong P, Deixler H, Funari TL, Bacino CA, Irons MB, Holm IA, Sadler L, Okenfuss EB, Janssens A, Voets T, Rimoin DL, Lachman RS, Nilius B, Cohn DH (2009) Mutations in the gene encoding the calcium-permeable ion channel TRPV4 produce Spondylometaphyseal dysplasia, Kozlowski type and metatropic dysplasia. Am J Hum Genet 84:307–315PubMedCrossRefGoogle Scholar
  72. 72.
    Kriz W (2005) TRPC6—a new podocyte gene involved in focal segmental glomerulosclerosis. Trends Mol Med 11:527–530PubMedCrossRefGoogle Scholar
  73. 73.
    Kruse M, Schulze-Bahr E, Corfield V, Beckmann A, Stallmeyer B, Kurtbay G, Ohmert I, Schulze-Bahr E, Brink P, Pongs O (2009) Impaired endocytosis of the ion channel TRPM4 is associated with human progressive familial heart block type I. J Clin Invest 119:2737–2744PubMedCrossRefGoogle Scholar
  74. 74.
    Kuhn FJ, Heiner I, Luckhoff A (2005) TRPM2: a calcium influx pathway regulated by oxidative stress and the novel second messenger ADP-ribose. Pflugers Arch Eur J Physiol 451:212–219CrossRefGoogle Scholar
  75. 75.
    Kwan HY, Huang Y, Yao X (2007) TRP channels in endothelial function and dysfunction. Biochim Biophys Acta 1772:907–914PubMedGoogle Scholar
  76. 76.
    Landouré G, Zdebik AA, Martinez TL, Burnett BG, Stanescu HC, Shi Y, Taye AA, Kong L, Choo SS, Phelps CB, Paudel R, Houlden H, Ludlow CL, Gaudet R, Kleta R, Fischbeck KH, Sumner CL (2010) Mutations in TRPV4 cause Charcot–Marie–Tooth disease type 2C. Nat Genet 42:170–174Google Scholar
  77. 77.
    Landry Y, Gies JP (2008) Drugs and their molecular targets: an updated overview. Fundam Clin Pharmacol 22:1–18PubMedCrossRefGoogle Scholar
  78. 78.
    LaPlante JM, Ye CP, Quinn SJ, Goldin E, Brown EM, Slaugenhaupt SA, Vassilev PM (2004) Functional links between mucolipin-1 and Ca2+-dependent membrane trafficking in mucolipidosis IV. Biochem Biophys Res Commun 322:1384–1391PubMedCrossRefGoogle Scholar
  79. 79.
    Leuenroth SJ, Okuhara D, Shotwell JD, Markowitz GS, Yu Z, Somlo S, Crews CM (2007) Triptolide is a traditional Chinese medicine-derived inhibitor of polycystic kidney disease. Proc Natl Acad Sci USA 104:4389–4394PubMedCrossRefGoogle Scholar
  80. 80.
    Li S, Gosling M, Poll CT, Westwick J, Cox B (2005) Therapeutic scope of modulation of non-voltage-gated cation channels. Drug Discov Today 10:129–137PubMedCrossRefGoogle Scholar
  81. 81.
    Li S, Westwick J, Cox B, Poll CT (2004) TRP channels as drug targets. Novartis Found Symp 258:204–213; discussion 213–221, 263–206PubMedCrossRefGoogle Scholar
  82. 82.
    Li X, Luo Y, Starremans PG, McNamara CA, Pei Y, Zhou J (2005) Polycystin-1 and polycystin-2 regulate the cell cycle through the helix-loop-helix inhibitor Id2. Nat Cell Biol 7:1102–1112CrossRefGoogle Scholar
  83. 83.
    Li Z, Sergouniotis PI, Michaelides M, Mackay DS, Wright GA, Devery S, Moore AT, Holder GE, Robson AG, Webster AR (2009) Recessive mutations of the gene TRPM1 abrogate ON bipolar cell function and cause complete congenital stationary night blindness in humans. Am J Hum Genet 85:711–719PubMedCrossRefGoogle Scholar
  84. 84.
    Liu J, Juo SH, Terwilliger JD, Grunn A, Tong X, Brito M, Loth JE, Kanyas K, Lerer B, Endicott J, Penchaszadeh G, Gilliam TC, Baron M (2001) A follow-up linkage study supports evidence for a bipolar affective disorder locus on chromosome 21q22. Am J Med Genet 105:189–194PubMedCrossRefGoogle Scholar
  85. 85.
    Luzio JP, Poupon V, Lindsay MR, Mullock BM, Piper RC, Pryor PR (2003) Membrane dynamics and the biogenesis of lysosomes. Mol Membr Biol 20:141–154PubMedCrossRefGoogle Scholar
  86. 86.
    Maxfield FR, McGraw TE (2004) Endocytic recycling. Nat Rev Mol Cell Biol 5:121–132PubMedCrossRefGoogle Scholar
  87. 87.
    McNulty S, Fonfria E (2005) The role of TRPM channels in cell death. Pflügers Arch Europ J Physiol 451:235–242CrossRefGoogle Scholar
  88. 88.
    Meng F, To WK, Gu Y (2008) Inhibition effect of arachidonic acid on hypoxia-induced [Ca(2+)](i) elevation in PC12 cells and human pulmonary artery smooth muscle cells. Respir Physiol Neurobiol 162:18–23PubMedCrossRefGoogle Scholar
  89. 89.
    Micsenyi MC, Dobrenis K, Stephney G, Pickel J, Vanier MT, Slaugenhaupt SA, Walkley SU (2009) Neuropathology of the Mcoln1(−/−) knockout mouse model of mucolipidosis type IV. J Neuropathol Exp Neurol 68:125–135PubMedCrossRefGoogle Scholar
  90. 90.
    Miller AJ, Du J, Rowan S, Hershey CL, Widlund HR, Fisher DE (2004) Transcriptional regulation of the melanoma prognostic marker melastatin (TRPM1) by MITF in melanocytes and melanoma. Cancer Res 64:509–516PubMedCrossRefGoogle Scholar
  91. 91.
    Miyagi K, Kiyonaka S, Yamada K, Miki T, Mori E, Kato K, Numata T, Sawaguchi Y, Numaga T, Kimura T, Kanai Y, Kawano M, Wakamori M, Nomura H, Koni I, Yamagishi M, Mori Y (2009) A pathogenic C-terminus-truncated polycystin-2 mutant enhances receptor-activated Ca2+ entry via association with TRPC3 and TRPC7. J Biol Chem 284:34400–34412PubMedCrossRefGoogle Scholar
  92. 92.
    Mizoguchi F, Mizuno A, Hayata T, Nakashima K, Heller S, Ushida T, Sokabe M, Miyasaka N, Suzuki M, Ezura Y, Noda M (2008) Transient receptor potential vanilloid 4 deficiency suppresses unloading-induced bone loss. Journal of Cell Physiology 216:47–53CrossRefGoogle Scholar
  93. 93.
    Mizuno A (2008) Mechanical stress and bone. TRP channels and mechanical stress. Clin Calcium 18:1304–1311PubMedGoogle Scholar
  94. 94.
    Morgans CW, Zhang J, Jeffrey BG, Nelson SM, Burke NS, Duvoisin RM, Brown RL (2009) TRPM1 is required for the depolarizing light response in retinal ON-bipolar cells. Proc Natl Acad Sci USA 106:19174–19178PubMedCrossRefGoogle Scholar
  95. 95.
    Mukerji N, Damodaran TV, Winn MP (2007) TRPC6 and FSGS: the latest TRP channelopathy. Biochim Biophys Acta 1772:859–868PubMedGoogle Scholar
  96. 96.
    Munns CF, Batch JA (2001) Hyperinsulinism and Beckwith–Wiedemann syndrome. Arch Dis Child Fetal Neonatal Ed 84:F67–F69PubMedCrossRefGoogle Scholar
  97. 97.
    Na T, Zhang W, Jiang Y, Liang Y, Ma HP, Warnock DG, Peng JB (2009) The A563T variation of the renal epithelial calcium channel TRPV5 among African Americans enhances calcium influx. Am J Physiol Renal Physiol 296:F1042–F1051PubMedCrossRefGoogle Scholar
  98. 98.
    Nagata K, Zheng L, Madathany T, Castiglioni AJ, Bartles JR, Garcia-Anoveros J (2008) The varitint-waddler (Va) deafness mutation in TRPML3 generates constitutive, inward rectifying currents and causes cell degeneration. Proc Natl Acad Sci USA 105:353–358PubMedCrossRefGoogle Scholar
  99. 99.
    Nakajima Y, Moriyama M, Hattori M, Minato N, Nakanishi S (2009) Isolation of ON bipolar cell genes via hrGFP-coupled cell enrichment using the mGluR6 promoter. J Biochem 145:811–818PubMedCrossRefGoogle Scholar
  100. 100.
    Nakaya K, Harbidge DG, Wangemann P, Schultz BD, Green E, Wall SM, Marcus DC (2007) Lack of pendrin HCO3− transport elevates vestibular endolymphatic [Ca2+] by inhibition of acid-sensitive TRPV5 and TRPV6 channels. Am J Physiol Renal Physiol 292:F1314–F1321PubMedCrossRefGoogle Scholar
  101. 101.
    Nilius B (2007) TRP channels in disease. Biochim Biophys Acta 1772:805–812PubMedGoogle Scholar
  102. 102.
    Nilius B, Mahieu F (2006) A road map for TRP(I)Ps. Molecular Cell 22:297–307PubMedCrossRefGoogle Scholar
  103. 103.
    Nilius B, Owsianik G (2010) Channelopathies converge on TRPV4. Nat Genet 42:98–100Google Scholar
  104. 104.
    Nilius B, Owsianik G, Voets T, Peters JA (2007) Transient receptor potential channels in disease. Physiol Rev 87:165–217PubMedCrossRefGoogle Scholar
  105. 105.
    Nilius B, Voets T (2005) Trp channels: a TR(I)P through a world of multifunctional cation channels. Pflügers Arch Europ J Physiol 451:1–10CrossRefGoogle Scholar
  106. 106.
    Ohba T, Watanabe H, Murakami M, Takahashi Y, Iino K, Kuromitsu S, Mori Y, Ono K, Iijima T, Ito H (2007) Upregulation of TRPC1 in the development of cardiac hypertrophy. J Mol Cell Cardiol 42:498–507PubMedCrossRefGoogle Scholar
  107. 107.
    Okuhara DY, Hsia AY, Xie M (2007) Transient receptor potential channels as drug targets. Expert Opin Ther Targets 11:391–401PubMedCrossRefGoogle Scholar
  108. 108.
    Otsuguro KI, Tang J, Tang Y, Xiao R, Freichel M, Tsvilovskyy V, Ito S, Flockerzi V, Zhu MX, Zholos AV (2008) Isoform-specific inhibition of TRPC4 channel by phosphatidylinositol 4, 5-bisphosphate. J Biol Chem 283:10026–10036PubMedCrossRefGoogle Scholar
  109. 109.
    Owsianik G, D'Hoedt D, Voets T, Nilius B (2006) Structure–function relationship of the TRP channel superfamily. Rev Physiol Biochem Pharmacol 156:61–90PubMedCrossRefGoogle Scholar
  110. 110.
    Owsianik G, Talavera K, Voets T, Nilius B (2006) Permeation and selectivity of TRP channels. Annu Rev Physiol 68:685–717PubMedCrossRefGoogle Scholar
  111. 111.
    Pani B, Singh BB (2008) Darier's disease: a calcium-signaling perspective. Cell Mol Life Sci 65:205–211PubMedCrossRefGoogle Scholar
  112. 112.
    Pedersen SF, Owsianik G, Nilius B (2005) TRP channels: an overview. Cell Calcium 38:233–252PubMedCrossRefGoogle Scholar
  113. 113.
    Pena F, Ordaz B (2008) Non-selective cation channel blockers: potential use in nervous system basic research and therapeutics. Mini Rev Med Chem 8:812–819PubMedCrossRefGoogle Scholar
  114. 114.
    Plato CC, Galasko D, Garruto RM, Plato M, Gamst A, Craig UK, Torres JM, Wiederholt W (2002) ALS and PDC of Guam: forty-year follow-up. Neurology 58:765–773PubMedGoogle Scholar
  115. 115.
    Plato CC, Garruto RM, Galasko D, Craig UK, Plato M, Gamst A, Torres JM, Wiederholt W (2003) Amyotrophic lateral sclerosis and parkinsonism-dementia complex of Guam: changing incidence rates during the past 60 years. Am J Epidemiol 157:149–157PubMedCrossRefGoogle Scholar
  116. 116.
    Prawitt D, Enklaar T, Klemm G, Gartner B, Spangenberg C, Winterpacht A, Higgins M, Pelletier J, Zabel B (2000) Identification and characterization of MTR1, a novel gene with homology to melastatin (MLSN1) and the trp gene family located in the BWS-WT2 critical region on chromosome 11p15.5 and showing allele-specific expression. Hum Mol Genet 9:203–216PubMedCrossRefGoogle Scholar
  117. 117.
    Prawitt D, Monteilh-Zoller MK, Brixel L, Spangenberg C, Zabel B, Fleig A, Penner R (2003) TRPM5 is a transient Ca2+-activated cation channel responding to rapid changes in [Ca2+]i. Proc Natl Acad Sci USA 100:15166–15171PubMedCrossRefGoogle Scholar
  118. 118.
    Puertollano R, Kiselyov K (2009) TRPMLs: in sickness and in health. Am J Physiol Renal Physiol 296:F1245–F1254PubMedCrossRefGoogle Scholar
  119. 119.
    Qian F, Noben-Trauth K (2005) Cellular and molecular function of mucolipins (TRPML) and polycystin 2 (TRPP2). Pflugers Arch Eur J Physiol 451:277–285CrossRefGoogle Scholar
  120. 120.
    Quadid-Ahidouch H, Ahidouch A (2007) K+ channel expression in human breast cancer cells: involvement in cell cycle regulation and carcinogenesis. J Membr Biol 221:1–6CrossRefGoogle Scholar
  121. 121.
    Ramsey IS, Delling M, Clapham DE (2006) An introduction to TRP channels. Annu Rev Physiol 68:619–647PubMedCrossRefGoogle Scholar
  122. 122.
    pt?>Raychowdhury MK, Gonzalez-Perrett S, Montalbetti N, Timpanaro GA, Chasan B, Goldmann WH, Stahl S, Cooney A, Goldin E, Cantiello HF (2004) Molecular pathophysiology of mucolipidosis type IV: pH dysregulation of the mucolipin-1 cation channel. Hum Mol Genet 13:617–627PubMedCrossRefGoogle Scholar
  123. 123.
    Reiser J, Polu KR, Moller CC, Kenlan P, Altintas MM, Wei C, Faul C, Herbert S, Villegas I, Avila-Casado C, McGee M, Sugimoto H, Brown D, Kalluri R, Mundel P, Smith PL, Clapham DE, Pollak MR (2005) TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function. Nat Genet 37:739–744PubMedCrossRefGoogle Scholar
  124. 124.
    Rock MJ, Prenen J, Funari VA, Funari TL, Merriman B, Nelson SF, Lachman RS, Wilcox WR, Reyno S, Roberto Quadrelli R, Vaglio A, Owsianik G, Janssens A, Voets T, Shiro Ikegawa S, Nagai T, Rimoin DL, Nilius B, Cohn DH (2008) Gain-of-function mutations in TRPV4 cause autosomal dominant brachyolmia. Nat Genet 40:999–1003PubMedCrossRefGoogle Scholar
  125. 125.
    Runnels LW, Yue L, Clapham DE (2001) TRP-PLIK, a bifunctional protein with kinase and ion channel activities. Science 291:1043–1047PubMedCrossRefGoogle Scholar
  126. 126.
    Samie MA, Grimm C, Evans JA, Curcio-Morelli C, Heller S, Slaugenhaupt SA, Cuajungco MP (2009) The tissue-specific expression of TRPML2 (MCOLN-2) gene is influenced by the presence of TRPML1. Pflugers Arch Eur J Physiol 459:79–91CrossRefGoogle Scholar
  127. 127.
    Scharenberg AM (2005) TRPM2 and TRPM7: channel/enzyme fusions to generate novel intracellular sensors. Pflugers Arch Eur J Physiol 451:220–227CrossRefGoogle Scholar
  128. 128.
    Schlingmann KP, Sassen MC, Weber S, Pechmann U, Kusch K, Pelken L, Lotan D, Syrrou M, Prebble JJ, Cole DE, Metzger DL, Rahman S, Tajima T, Shu SG, Waldegger S, Seyberth HW, Konrad M (2005) Novel TRPM6 mutations in 21 families with primary hypomagnesemia and secondary hypocalcemia. J Am Soc Nephrol 16:3061–3069PubMedCrossRefGoogle Scholar
  129. 129.
    Schlingmann KP, Weber S, Peters M, Niemann Nejsum L, Vitzthum H, Klingel K, Kratz M, Haddad E, Ristoff E, Dinour D, Syrrou M, Nielsen S, Sassen M, Waldegger S, Seyberth HW, Konrad M (2002) Hypomagnesemia with secondary hypocalcemia is caused by mutations in TRPM6, a new member of the TRPM gene family. Nat Genet 31:166–170PubMedCrossRefGoogle Scholar
  130. 130.
    Schlöndorff J, del Camino D, Carrasquillo R, Lacey V, Pollak MR (2009) TRPC6 mutations associated with focal segmental glomerulosclerosis cause constitutive activation of NFAT dependent transcription. Am J Physiol 296:C558–C569CrossRefGoogle Scholar
  131. 131.
    Schmitz C, Perraud AL, Johnson CO, Inabe K, Smith MK, Penner R, Kurosaki T, Fleig A, Scharenberg AM (2003) Regulation of vertebrate cellular Mg2+ homeostasis by TRPM7. Cell 114:191–200PubMedCrossRefGoogle Scholar
  132. 132.
    Shimizu T, Janssens A, Voets T, Nilius B (2008) Regulation of the murine TRPP3 channel by voltage, pH, and changes in cell volume. Pflugers Arch Eur J Physiol 457:795–807Google Scholar
  133. 133.
    Slaugenhaupt SA (2002) The molecular basis of mucolipidosis type IV. Curr Mol Med 2:445–450PubMedCrossRefGoogle Scholar
  134. 134.
    Somlo S, Markowitz GS (2000) The pathogenesis of autosomal dominant polycystic kidney disease: an update. Curr Opin Nephrol Hypertens 9:385–394PubMedCrossRefGoogle Scholar
  135. 135.
    Soyombo AA, Tjon-Kon-Sang S, Rbaibi Y, Bashllari E, Bisceglia J, Muallem S, Kiselyov K (2006) TRP-ML1 regulates lysosomal pH and acidic lysosomal lipid hydrolytic activity. J Biol Chem 281:7294–7301PubMedCrossRefGoogle Scholar
  136. 136.
    Stiber JA, Seth M, Rosenberg PB (2009) Mechanosensitive channels in striated muscle and the cardiovascular system: not quite a stretch anymore. J Cardiovasc Pharmacol 54:116–122PubMedCrossRefGoogle Scholar
  137. 137.
    Straub RE, Lehner T, Luo Y, Loth JE, Shao W, Sharpe L, Alexander JR, Das K, Simon R, Fieve RR, Lerer B, Endicott J, Ott J, Gilliam TC, Baron M (1994) A possible vulnerability locus for bipolar affective disorder on chromosome 21q22.3. Nat Genet 8:291–296PubMedCrossRefGoogle Scholar
  138. 138.
    Strubing C, Krapivinsky G, Krapivinsky L, Clapham DE (2001) TRPC1 and TRPC5 form a novel cation channel in mammalian brain. Neuron 29:645–655PubMedCrossRefGoogle Scholar
  139. 139.
    Strubing C, Krapivinsky G, Krapivinsky L, Clapham DE (2003) Formation of novel TRPC channels by complex subunit interactions in embryonic brain. J Biol Chem 278:39014–39019PubMedCrossRefGoogle Scholar
  140. 140.
    Sun M, Goldin E, Stahl S, Falardeau JL, Kennedy JC, Acierno JS Jr, Bove C, Kaneski CR, Nagle J, Bromley MC, Colman M, Schiffmann R, Slaugenhaupt SA (2000) Mucolipidosis type IV is caused by mutations in a gene encoding a novel transient receptor potential channel. Hum Mol Genet 9:2471–2478PubMedCrossRefGoogle Scholar
  141. 141.
    Sutters M, Germino GG (2003) Autosomal dominant polycystic kidney disease: molecular genetics and pathophysiology. J Lab Clin Med 141:91–101PubMedCrossRefGoogle Scholar
  142. 142.
    Suzuki Y, Pasch A, Bonny O, Mohaupt MG, Hediger MA, Frey FJ (2008) Gain of function haplotype in the epithelial calcium channel TRPV6 is a risk factor for renal calcium stone formation. Hum Mol Genet 17:1613–1618PubMedCrossRefGoogle Scholar
  143. 143.
    Szallasi A, Cortright DN, Blum CA, Eid SR (2007) The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept. Nat Rev Drug Discov 6:357–372PubMedCrossRefGoogle Scholar
  144. 144.
    Takamori M (2008) Autoantibodies against TRPC3 and ryanodine receptor in myasthenia gravis. J Neuroimmunol 200:142–144PubMedCrossRefGoogle Scholar
  145. 145.
    Thorneloe KS, Sulpizio AC, Lin Z, Figueroa DJ, Clouse AK, McCafferty GP, Chendrimada TP, Lashinger ES, Gordon EA, Evans L, Misajet BA, Demarini DJ, Nation JH, Casillas LN, Marquis RW, Votta BJ, Sheardown SA, Xu X, Brooks DP, Laping N, Westfall TD (2008) GSK1016790A, a novel and potent TRPV4 channel agonist induces urinary bladder contraction and hyperactivity: part I. J Pharmacol Exp Ther 326:432–442PubMedCrossRefGoogle Scholar
  146. 146.
    Tian W, Fu Y, Garcia-Elias A, Fernandez-Fernandez JM, Vicente R, Kramer PL, Klein RF, Hitzemann R, Orwoll ES, Wilmot B, McWeeney S, Valverde MA, Cohen DM (2009) A loss-of-function nonsynonymous polymorphism in the osmoregulatory TRPV4 gene is associated with human hyponatremia. Proc Natl Acad Sci USA 106:14034–14039PubMedCrossRefGoogle Scholar
  147. 147.
    van Genderen MM, Bijveld MM, Claassen YB, Florijn RJ, Pearring JN, Meire FM, McCall MA, Riemslag FC, Gregg RG, Bergen AA, Kamermans M (2009) Mutations in TRPM1 are a common cause of complete congenital stationary night blindness. Am J Hum Genet 85:730–736PubMedCrossRefGoogle Scholar
  148. 148.
    Venkatachalam K, Hofmann T, Montell C (2006) Lysosomal localization of TRPML3 depends on TRPML2 and the mucolipidosis-associated protein TRPML1. J Biol Chem 281:17517–17527PubMedCrossRefGoogle Scholar
  149. 149.
    Venkatachalam K, Montell C (2007) TRP channels. Annu Rev Biochem 76:387–417PubMedCrossRefGoogle Scholar
  150. 150.
    Venkatachalam K, van Rossum DB, Patterson RL, Ma HT, Gill DL (2002) The cellular and molecular basis of store-operated calcium entry. Nat Cell Biol 4:E263–E272PubMedCrossRefGoogle Scholar
  151. 151.
    Venkatachalam K, Zheng F, Gill DL (2003) Regulation of canonical transient receptor potential (TRPC) channel function by diacylglycerol and protein kinase C. J Biol Chem 278:29031–29040PubMedCrossRefGoogle Scholar
  152. 152.
    Vennekens R, Owsianik G, Nilius B (2008) Vanilloid transient receptor potential cation channels: an overview. Curr Pharm Des 14:18–31PubMedCrossRefGoogle Scholar
  153. 153.
    Venugopal B, Mesires NT, Kennedy JC, Curcio-Morelli C, Laplante JM, Dice JF, Slaugenhaupt SA (2008) Chaperone-mediated autophagy is defective in mucolipidosis type IV. J Cell Physiol 219:344–353CrossRefGoogle Scholar
  154. 154.
    Vergarajauregui S, Oberdick R, Kiselyov K, Puertollano R (2008) Mucolipin 1 channel activity is regulated by protein kinase A-mediated phosphorylation. Biochem J 410:417–425PubMedCrossRefGoogle Scholar
  155. 155.
    Vergarajauregui S, Puertollano R (2008) Mucolipidosis type IV: the importance of functional lysosomes for efficient autophagy. Autophagy 4:832–834PubMedGoogle Scholar
  156. 156.
    Voets T, Nilius B, Hoefs S, van der Kemp AW, Droogmans G, Bindels RJ, Hoenderop JG (2004) TRPM6 forms the Mg2+ influx channel involved in intestinal and renal Mg2+ absorption. J Biol Chem 279:19–25PubMedCrossRefGoogle Scholar
  157. 157.
    Voets T, Talavera K, Owsianik G, Nilius B (2005) Sensing with TRP channels. Nature Biol Chem 1:85–92CrossRefGoogle Scholar
  158. 158.
    Vriens J, Owsianik G, Janssens A, Voets T, Nilius B (2007) Determinants of 4alpha-phorbol sensitivity in transmembrane domains 3 and 4 of the cation channel TRPV4. J Biol Chem 282:12796–12803PubMedCrossRefGoogle Scholar
  159. 159.
    Walder RY, Landau D, Meyer P, Shalev H, Tsolia M, Borochowitz Z, Boettger MB, Beck GE, Englehardt RK, Carmi R, Sheffield VC (2002) Mutation of TRPM6 causes familial hypomagnesemia with secondary hypocalcemia. Nat Genet 31:171–174PubMedCrossRefGoogle Scholar
  160. 160.
    Walz G (2005) Slit or pore? A mutation of the ion channel TRPC6 causes FSGS. Nephrol Dial Transplant 20:1777–1779PubMedCrossRefGoogle Scholar
  161. 161.
    Wangemann P, Nakaya K, Wu T, Maganti RJ, Itza EM, Sanneman JD, Harbidge DG, Billings S, Marcus DC (2007) Loss of cochlear HCO3− secretion causes deafness via endolymphatic acidification and inhibition of Ca2+ reabsorption in a Pendred syndrome mouse model. Am J Physiol Renal Physiol 292:F1345–F1353PubMedCrossRefGoogle Scholar
  162. 162.
    Willette R, Bao W, Nerurkar S, Yue TL, Doe CP, Stankus G, Turner GH, Ju H, Thomas H, Fishman C, Sulpizio A, Behm D, Hoffman S, Lin Z, Lozinskaya I, Casillas L, Lin M, Trout RE, Thorneloe K, Lashinger ES, Figueroa DJ, Votta B, Marquis R, Xu X (2008) Systemic activation of the transient receptor potential v4 channel causes endothelial failure and circulatory collapse: part 2. J Pharmacol Exp Ther 326:443–452PubMedCrossRefGoogle Scholar
  163. 163.
    Winn MP, Conlon PJ, Lynn KL, Farrington MK, Creazzo T, Hawkins AF, Daskalakis N, Kwan SY, Eversviller S, Burchette JL, Pericak-Vance MA, Howell DN, Vance JM, Rosenberg PB (2005) A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis. Science 308:1801–1804PubMedCrossRefGoogle Scholar
  164. 164.
    Winn MP, Daskalakis N, Spurney RF, Middleton JP (2006) Unexpected role of TRPC6 channel in familial nephrotic syndrome: does it have clinical implications? J Am Soc Nephrol 17:378–387PubMedCrossRefGoogle Scholar
  165. 165.
    Woodcock EA, Kistler PM, Kun Ju YK (2008) Phosphoinositide signalling and cardiac arrhythmias. Cardiovasc Res 82:286–295PubMedCrossRefGoogle Scholar
  166. 166.
    Woudenberg-Vrenken TE, Bindels RJ, Hoenderop JG (2009) The role of transient receptor potential channels in kidney disease. Nat Rev Nephrol 5:441–449PubMedCrossRefGoogle Scholar
  167. 167.
    Wu G, Markowitz GS, Li L, D'Agati VD, Factor SM, Geng L, Tibara S, Tuchman J, Cai Y, Park JH, van Adelsberg J, Hou H Jr, Kucherlapati R, Edelmann W, Somlo S (2000) Cardiac defects and renal failure in mice with targeted mutations in Pkd2. Nat Genet 24:75–78PubMedCrossRefGoogle Scholar
  168. 168.
    Xu C, Li PP, Cooke RG, Parikh SV, Wang K, Kennedy JL, Warsh JJ (2009) TRPM2 variants and bipolar disorder risk: confirmation in a family-based association study. Bipolar Disord 11:1–10PubMedCrossRefGoogle Scholar
  169. 169.
    Xu C, Macciardi F, Li PP, Yoon IS, Cooke RG, Hughes B, Parikh SV, McIntyre RS, Kennedy JL, Warsh JJ (2006) Association of the putative susceptibility gene, transient receptor potential protein melastatin type 2, with bipolar disorder. Am J Med Genet B Neuropsychiatr Genet 141:36–43Google Scholar
  170. 170.
    Xu H, Delling M, Li L, Dong X, Clapham DE (2007) Activating mutation in a mucolipin transient receptor potential channel leads to melanocyte loss in varitint-waddler mice. Proc Natl Acad Sci USA 104:18321–18326PubMedCrossRefGoogle Scholar
  171. 171.
    Yao X, Garland CJ (2005) Recent developments in vascular endothelial cell transient receptor potential channels. Circ Res 97:853–863PubMedCrossRefGoogle Scholar
  172. 172.
    Yu Y, Keller SH, Remillard CV, Safrina O, Nicholson A, Zhang SL, Jiang W, Vangala N, Landsberg JW, Wang JY, Thistlethwaite PA, Channick RN, Robbins IM, Loyd JE, Ghofrani HA, Grimminger F, Schermuly RT, Cahalan MD, Rubin LJ, Yuan JX (2009) A functional single-nucleotide polymorphism in the TRPC6 gene promoter associated with idiopathic pulmonary arterial hypertension. Circulation 119:2313–2322PubMedCrossRefGoogle Scholar
  173. 173.
    Zeevi DA, Frumkin A, Bach G (2007) TRPML and lysosomal function. Biochim Biophys Acta 1772:851–858PubMedGoogle Scholar
  174. 174.
    Zhang F, Jin S, Yi F, Li PL (2008) TRP-ML1 functions as a lysosomal NAADP-sensitive Ca(2+) release channel in coronary arterial myocytes. J Cell Mol Med (in press)Google Scholar
  175. 175.
    Zhu B, Chen N, Wang ZH, Pan XX, Ren H, Zhang W, Wang WM (2009) Identification and functional analysis of a novel TRPC6 mutation associated with late onset familial focal segmental glomerulosclerosis in Chinese patients. Mutat Res 664:84–90PubMedGoogle Scholar
  176. 176.
    Zong X, Schieder M, Cuny H, Fenske S, Gruner C, Rotzer K, Griesbeck O, Harz H, Biel M, Wahl-Schott C (2009) The two-pore channel TPCN2 mediates NAADP-dependent Ca(2+)-release from lysosomal stores. Pflugers Arch Eur J Physiol 458:891–899CrossRefGoogle Scholar
  177. 177.
    Zufall F, Ukhanov K, Lucas P, Liman ER, Leinders-Zufall T (2005) Neurobiology of TRPC2: from gene to behaviour. Pflugers Arch Eur J Physiol 451:61–71CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  1. 1.Laboratory Ion Channel Research, Department of Molecular Cell BiologyKU LeuvenLeuvenBelgium

Personalised recommendations